EVIDENCE THAT THE 5-HT1A RECEPTOR AGONISTS BUSPIRONE AND IPSAPIRONE ACTIVATE ADRENALINE RELEASE IN THE CONSCIOUS RAT

被引:39
作者
CHAOULOFF, F
BAUDRIE, V
LAUDE, D
机构
[1] Laboratoire de Pharmacologie, Groupe de Neuropharmacologie, INSERM U7
关键词
5-HT[!sub]1A[!/sub] receptors; Adrenaline; Buspirone; Glycemia; Ipsapirone;
D O I
10.1016/0014-2999(90)90558-N
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to investigate the effects of the 5-HT1A receptor agonists buspirone and ipsapirone (1-10 mg/kg) on plasma adrenaline (A) levels and on glycemia in the conscious rat. The results indicate that buspirone was able, within 5 min, to increase plasma A and glucose levels in a dose-dependent manner. Ipsapirone administration triggered similar patterns, except that the highest dose used (10 mg/kg) promoted a time-dependent increase in plasma A and glucose levels that was maximal at the end of analysis. © 1990.
引用
收藏
页码:107 / 110
页数:4
相关论文
共 10 条
[1]   MARKED INCREASES IN PLASMA-CATECHOLAMINE CONCENTRATIONS PRECEDE HYPOTENSION AND BRADYCARDIA CAUSED BY 8-HYDROXY-2-(DI-N-PROPYLAMINO) TETRALIN (8-OH-DPAT) IN CONSCIOUS RATS [J].
BAGDY, G ;
SZEMEREDI, K ;
MURPHY, DL .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1989, 41 (04) :270-272
[2]  
CHAOULOFF F, 1987, J PHARMACOL EXP THER, V243, P1159
[3]   HYPERINSULINEMIA OF THE GENETICALLY-OBESE (FA/FA) RAT IS DECREASED BY A LOW-DOSE OF THE 5-HT1A RECEPTOR AGONIST 8-HYDROXY-2-(DI-NORMAL-PROPYLAMINO)TETRALIN (8-OH-DPAT) [J].
CHAOULOFF, F ;
JEANRENAUD, B .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 147 (01) :111-118
[4]  
CHAOULOFF F, IN PRESS ARCH PHARM
[5]   ACTIVATION OF THE 5-HT1A RECEPTOR SUBTYPE INCREASES RAT PLASMA ACTH CONCENTRATION [J].
GILBERT, F ;
BRAZELL, C ;
TRICKLEBANK, MD ;
STAHL, SM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 147 (03) :431-439
[6]  
KEETON TK, 1989, EUR J PHARMACOL, V164, P479
[7]   8-HYDROXY-2-(DI-NORMAL-PROPYLAMINO)-TETRALIN DISCRIMINATES BETWEEN SUBTYPES OF THE 5-HT1 RECOGNITION SITE [J].
MIDDLEMISS, DN ;
FOZARD, JR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 90 (01) :151-153
[8]   SELECTIVE INTERACTION OF NOVEL ANXIOLYTICS WITH 5-HYDROXYTRYPTAMINE1A RECEPTORS [J].
PEROUTKA, SJ .
BIOLOGICAL PSYCHIATRY, 1985, 20 (09) :971-979
[9]   EVIDENCE THAT THE NOVEL ANTIHYPERTENSIVE AGENT, FLESINOXAN, CAUSES DIFFERENTIAL SYMPATHOINHIBITION AND ALSO INCREASES VAGAL TONE BY A CENTRAL ACTION [J].
RAMAGE, AG ;
WOUTERS, W ;
BEVAN, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 151 (03) :373-379
[10]   5-HT1A RECEPTOR-RELATED ANXIOLYTICS [J].
TRABER, J ;
GLASER, T .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1987, 8 (11) :432-437